DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Referenz

Erlinge D, James S, Duvvuru S. , et al.
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

Thromb Haemost 2014;
111 (05) 943-950

Erlinge D, James S, Duvvuru S. , et al.
Clopidogrel metaboliser status based on point-of-care CYP2C19 genetic testing in patients with coronary artery disease.

Thromb Haemost 2014;
111 (05) 943-950

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: